2m 2m 2m 2m 2m 2m 2m
ALTO NEURO (ANRO)
NYSE
$18.97+$0.26 (+1.39%)
Price as of Jun 03, 2026 7:28 PM EDT- $704.3MMarket Cap
- 611.41%1-Year Change
- BiotechnologyIndustry
ALTO NEURO (ANRO)
$18.97+$0.26 (+1.39%)
ANRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.71 | ||
Change | -$1.09 (-5.51%) | ||
Open | $19.53 | ||
High | $19.88 | ||
Low | $18.47 | ||
Previous Close | $19.80 | ||
Volume | 321,145 | ||
30-Day Average Volume | 326,807 | ||
1-Week Change | -11.16% | ||
1-Month Change | -24.98% | ||
1-Year Change | 611.41% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 35.1M | ||
Total Assets | $276.3M | ||
Market Cap | $704.3M | ||
Enterprise Value | $458.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$26.2M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$25.7M | ||
EBITDA | -$25.6M | ||
Net Working Capital | $256.0M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -25 | ||
PEG | 0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue